Impacts of the COVID-19 pandemic on the epidemiology of Leishmaniasis Diffuse Cutaneous in Brazil
Keywords:
Leishmaniasis Diffuse Cutaneous, Leishmaniasis, Cutaneous, COVID-19Abstract
Objective: To analyze the incidence of Leishmaniasis Diffuse Cutaneous (LDC) before and during the COVID-19 pandemic in Brazilian regions. Methods: Ecological study conducted using data from the Notifiable Diseases System (SINAN). LDC cases in Brazil were investigated in the years 2017-2019 and 2020-2022. The proportions and frequencies of cases were calculated by region and analyzed periods, comparing the distribution and evolution of records. Results: Of the 73,604 confirmed cases, there was an 8.2% reduction between the two periods. The North and Northeast regions, respectively, had the highest numbers of cases in both periods, with an increase in disease incidence. In contrast, the other regions had decreases during the pandemic. Conclusion: There was a reduction in reported cases, with evident regional disparities, even more intensified in the COVID-19 era. The research reinforces the importance of strengthening surveillance systems to continue tackling neglected diseases like ACL.
References
Menezes JA, Luz TCB, Sousa FF de, Verne RN, Lima FP, Margonari C. Fatores de risco peridomiciliares e conhecimento sobre leishmaniose visceral da população de Formiga, Minas Gerais. Rev Bras Epidemiol. 2016;19(2):362–74. Available from:https://www.scielo.br/j/rbepid/a/STnv3Cpm3H8w53MqpZMHMQp/. Accessed: 11 Nov 2024
Bamorovat M, Sharifi I, Bafti MS, Afshari SAK, Aflatoonian MR, Karamoozian A, et al.. Cutaneous Leishmaniasis Hampers COVID-19: A Controlled Cross-Sectional Study in High-Burden Endemic Areas of Iran. Journal of Epidemiology and Global Health. 2024;14(1):142-153. Available from:https://link.springer.com/article/10.1007/s44197-023-00179-0. Accessed: 11 Nov 2024.
Andrade MC, Bonan PRF, Hilan E, Marques NP, Guimarães-Carvalho SF, HM Junior. COVID-19 pandemic causes increased clinic visits with diagnosis of tegumentary leishmaniasis in Brazil in 2020. International Journal of Infectious Diseases. 2021;113(1):87-89. Available from:https://www.sciencedirect.com/science/article/pii/S1201971221007955. Accessed: 11 de nov. 2024.
Oliveira RS, Pimentel KBA, Moura MES, Pinheiro VCS. Impact of COVID-19 on the registration of tegumentary leishmaniasis cases in Maranhão, Brazil. Rev Epidemiol Control Infec. 2023;13(3):18352. Available from:https://online.unisc.br/seer/index.php/epidemiologia/article/view/18352. Accessed: 11 Nov 2024.
Polidano K, Parton L, Agampodi SB, Agampodi TC, Haileselassie BH, Lalani JMG, et al. Community engagement in cutaneous leishmaniasis research in Brazil, Ethiopia, and Sri Lanka: a decolonial approach for global health. Front Public Health. 2022;10:823844. Available from: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.823844/full. Accessed: 11 Nov 2024.
Carvalho SFG, Vieira TM, Moura APV, Andrade MC. Deve-se considerar uma intersecção entre a leishmaniose visceral, a endemicidade e a pandemia de COVID-19? Med Hypotheses. 2020;144:110289. Available from: https://www.sciencedirect.com/science/article/pii/S0306987720328152. Accessed: 11 Nov 2024.
Criado PR, Abdalla BMZ, Assis IC, Van Blarcum de Graaff Melo C, Caputo GC, Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflammation Research. 2020;69:745-756.. Available from: https://link.springer.com/article/10.1007/s00011-020-01370-w. Accessed: 11 Nov 2024.
Cestari S, Cestari M, Marques G, Lírio I, Tovo R, Labriola IC. Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review. An Bras Dermatol. 2023;98(4):466-471. Available from: https://www.scielo.br/j/abd/a/Vxw5684YgmPsgf5JfFQPHLL/?lang=en. Acessed: 11 Nov 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista de Divulgação Científica Sena Aires
This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
